Roche Pharma (Scheweiz) AG
- L01 - Antineoplásicos
- AVASTIN concentrate for solution for infusion 100 mg/4 ml
- AVASTIN concentrate for solution for infusion 400 mg/16 ml
- HERCEPTIN powder for solution for infusion 150 mg
- MABTHERA concentrate for solution for infusion 1 400 mg/11.7 ml
- MABTHERA concentrate for solution for infusion 100 mg/10 ml
- MABTHERA concentrate for solution for infusion 500 mg/50 ml
- PERJETA concentrate for solution for infusion 420 mg/14 ml
- L03 - Inmunoestimulantes
- PEGASYS solution for injection 180 µg/0.5 ml
- L04 - Inmunosupresores
- ACTEMRA concentrate for solution for infusion 200 mg/10 ml
- ACTEMRA concentrate for solution for infusion 400 mg/20 ml
- ACTEMRA concentrate for solution for infusion 80 mg/4 ml
- ACTEMRA solution for injection 162 mg/0.9 mL
- OCREVUS concentrate for solution for infusion 300 mg/10 ml